Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01084525 · ClinicalTrials.gov registry record · Phase 1
OTO-104 for Meniere's Disease
A Phase 1 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01084525 is a Phase 1 study that has completed, run by Otonomy. The registered enrollment target is 44 participants.
The verdict
NCT01084525, a Phase 1 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of OTO-104 in subjects with unilateral Meniere's disease. The effectiveness of OTO-104 to reduce the symptoms of Meniere's disease will also be evaluated.
Interventions
- DRUG Placebo
- DRUG OTO-104 (steroid) 3 mg
- DRUG OTO-104 (steroid) 12 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01084525
The ClinicalTrials.gov registry entry for NCT01084525 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01084525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01084525 about?
NCT01084525 is a clinical study titled "OTO-104 for Meniere's Disease". The purpose of this study is to evaluate the safety of OTO-104 in subjects with unilateral Meniere's disease. The effectiveness of OTO-104 to reduce the symptoms of Meniere's disease will also be evaluated.
What is the current status of trial NCT01084525?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2010-03. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01084525?
The interventions under investigation include: Placebo (DRUG), OTO-104 (steroid) 3 mg (DRUG), OTO-104 (steroid) 12 mg (DRUG).
Who is sponsoring clinical trial NCT01084525?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.